Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers

Frontiers in Bioscience

Volumn 12, Issue 6, 2007, Pages 2063-2073

  Dyrskjot, Lars ^a   Zieger, Karsten ^a   Orntoft, Torben Falck ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Array; Biomarker; Bladder cancer; Diagnosis; Gene expression; Microarray; Prognosis; Review; SNP; Tissue microarray

Indexed keywords

TUMOR MARKER;

BLADDER TUMOR; CANCER INVASION; CARCINOMA; CLASSIFICATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; PATHOLOGY; PROGNOSIS; PROTEIN MICROARRAY; REVIEW;

CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 36048966839     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2211     Document Type: Article

References (63)

1. Holmang S, H. Hedelin, C. Anderstrom & S. L. Johansson: The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 153, 1823-1826; discussion 1826-1827 (1995)
2. Zieger K, H. Wolf, P. R. Olsen & K. Hojgaard: Long-term follow-up of noninvasive bladder tumours (stage Ta): recurrence and progression. BJU Int 85, 824-828 (2000) (Pubitemid 30242785)
3. Witjes J. A, C. T. Caris, N. A. Mungan, F. M. Debruyne & W. P. Witjes: Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. J Urol 160, 1668-1671; discussion 1671-1662 (1998)
4. Holmang S, P. Andius, H. Hedelin, K. Wester, C. Busch & S. L. Johansson: Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 165, 1124-1128; discussion 1128-1130 (2001)
5. Zieger K, L. Dyrskjot, C. Wiuf, J. L. Jensen, C. L. Andersen, K. M. Jensen & T. F. Orntoft: Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors. Clin Cancer Res 11, 7709-7719 (2005) (Pubitemid 41611613)
6. Schrier B. P, M. P. Hollander, B. W. van Rhijn, L. A. Kiemeney & J. A. Witjes: Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45, 292-296 (2004) (Pubitemid 38221401)
7. Zieger K, P. R. Olsen, H. Wolf & K. Hojgaard: Long term follow-up of superficial invasive bladder carcinoma with or without concomitant epithelial atypia-recurrence and progression. Scand J Urol Nephrol 36, 52-59 (2002) (Pubitemid 34225303)
8. Wolf H & K. Hojgaard: Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences. Lancet 2, 134-136 (1983) (Pubitemid 13067429)
9. Hurle R, A. Losa, A. Manzetti & A. Lembo: Intravesical bacille Calmette-Guerin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up. Urology 54, 258-263 (1999) (Pubitemid 29367248)
10. Lebret T, D. Bohin, Z. Kassardjian, J. M. Herve, V. Molinie, P. Barre, P. M. Lugagne & H. Botto: Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. J Urol 163, 63-67 (2000)
11. Cookson M. S, H. W. Herr, Z. F. Zhang, S. Soloway, P. C. Sogani & W. R. Fair: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158, 62-67 (1997) (Pubitemid 27251595)
12. Oosterlinck W: The management of superficial bladder cancer. BJU Int 87, 135-140 (2001) (Pubitemid 32094854)
13. McShane L. M, D. G. Altman, W. Sauerbrei, S. E. Taube, M. Gion & G. M. Clark: Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97, 1180-1184 (2005) (Pubitemid 41258223)
14. van Rhijn B. W, A. N. Vis, T. H. van der Kwast, W. J. Kirkels, F. Radvanyi, E. C. Ooms, D. K. Chopin, E. R. Boeve, A. C. Jobsis & E. C. Zwarthoff: Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol 21, 1912-1921 (2003) (Pubitemid 46606378)
15. Sidransky D, P. Frost, A. Von Eschenbach, R. Oyasu, A. C. Preisinger & B. Vogelstein: Clonal origin bladder cancer. N Engl J Med 326, 737-740 (1992)
16. Muto S, S. Horie, S. Takahashi, K. Tomita & T. Kitamura: Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer. Cancer Res 60, 4021-4025 (2000) (Pubitemid 30636576)
17. Stoehr R, A. Hartmann, E. Hiendlmeyer, K. Murle, W. Wieland & R. Knuechel: Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis. Pathobiology 68, 165-172 (2000) (Pubitemid 32247251)
18. Simon R, E. Eltze, K. L. Schafer, H. Burger, A. Semjonow, L. Hertle, B. Dockhorn-Dworniczak, H. J. Terpe & W. Bocker: Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 61, 355-362 (2001) (Pubitemid 32095738)
19. van Rhijn B. W, H. G. van der Poel & T. H. van der Kwast: Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 47, 736-748 (2005) (Pubitemid 40745338)
20. Grossman H. B, M. Soloway, E. Messing, G. Katz, B. Stein, V. Kassabian & Y. Shen: Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. Jama 295, 299-305 (2006) (Pubitemid 43112958)
21. Messing E. M, L. Teot, H. Korman, E. Underhill, E. Barker, B. Stork, J. Qian & D. G. Bostwick: Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States. J Urol 174, 1238-1241 (2005) (Pubitemid 41318690)
22. Lokeshwar V. B, T. Habuchi, H. B. Grossman, W. M. Murphy, S. H. Hautmann, G. P. Hemstreet, 3rd, A. V. Bono, R. H. Getzenberg, P. Goebell, B. J. Schmitz-Drager, J. A. Schalken, Y. Fradet, M. Marberger, E. Messing & M. J. Droller: Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology 66, 35-63 (2005) (Pubitemid 43049608)
23. Wu X. R: Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5, 713-725 (2005)
24. Sylvester R. J, A. P. van der Meijden, J. A. Witjes & K. Kurth: Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174, 86-91; discussion 91-82 (2005)
25. Witjes J. A: Management of BCG Failures in Superficial Bladder Cancer: A Review. Eur Urol 49, 790-797 (2006)
26. Fokdal L, M. Hoyer & H. von der Maase: Radical radiotherapy for urinary bladder cancer: treatment outcomes. Expert Rev Anticancer Ther 6, 269-279 (2006) (Pubitemid 44192938)
27. Venter J. C, M. D. Adams, E. W. Myers, P. W. Li, R. J. Mural, G. G. Sutton, H. O. Smith, M. Yandell, C. A. Evans, R. A. Holt, J. D. Gocayne, P. Amanatides, R. M. Ballew, D. H. Huson, J. R. Wortman, Q. Zhang, C. D. Kodira, X. H. Zheng, L. Chen, M. Skupski, G. Subramanian, P. D. Thomas, J. Zhang, G. L. Gabor Miklos, C. Nelson, S. Broder, A. G. Clark, J. Nadeau, V. A. McKusick, N. Zinder, A. J. Levine, R. J. Roberts, M. Simon, C. Slayman, M. Hunkapiller, R. Bolanos, A. Delcher, I. Dew, D. Fasulo, M. Flanigan, L. Florea, A. Halpern, S. Hannenhalli, S. Kravitz, S. Levy, C. Mobarry, K. Reinert, K. Remington, J. Abu-Threideh, E. Beasley, K. Biddick, V. Bonazzi, R. Brandon, M. Cargill, I. Chandramouliswaran, R. Charlab, K. Chaturvedi, Z. Deng, V. Di Francesco, P. Dunn, K. Eilbeck, C. Evangelista, A. E. Gabrielian, W. Gan, W. Ge, F. Gong, Z. Gu, P. Guan, T. J. Heiman, M. E. Higgins, R. R. Ji, Z. Ke, K. A. Ketchum, Z. Lai, Y. Lei, Z. Li, J. Li, Y. Liang, X. Lin, F. Lu, G. V. Merkulov, N. Milshina, H. M. Moore, A. K. Naik, V. A. Narayan, B. Neelam, D. Nusskern, D. B. Rusch, S. Salzberg, W. Shao, B. Shue, J. Sun, Z. Wang, A. Wang, X. Wang, J. Wang, M. Wei, R. Wides, C. Xiao, C. Yan, A. Yao, J. Ye, M. Zhan, W. Zhang, H. Zhang, Q. Zhao, L. Zheng, F. Zhong, W. Zhong, S. Zhu, S. Zhao, D. Gilbert, S. Baumhueter, G. Spier, C. Carter, A. Cravchik, T. Woodage, F. Ali, H. An, A. Awe, D. Baldwin, H. Baden, M. Barnstead, I. Barrow, K. Beeson, D. Busam, A. Carver, A. Center, M. L. Cheng, L. Curry, S. Danaher, L. Davenport, R. Desilets, S. Dietz, K. Dodson, L. Doup, S. Ferriera, N. Garg, A. Gluecksmann, B. Hart, J. Haynes, C. Haynes, C. Heiner, S. Hladun, D. Hostin, J. Houck, T. Howland, C. Ibegwam, J. Johnson, F. Kalush, L. Kline, S. Koduru, A. Love, F. Mann, D. May, S. McCawley, T. McIntosh, I. McMullen, M. Moy, L. Moy, B. Murphy, K. Nelson, C. Pfannkoch, E. Pratts, V. Puri, H. Qureshi, M. Reardon, R. Rodriguez, Y. H. Rogers, D. Romblad, B. Ruhfel, R. Scott, C. Sitter, M. Smallwood, E. Stewart, R. Strong, E. Suh, R. Thomas, N. N. Tint, S. Tse, C. Vech, G. Wang, J. Wetter, S. Williams, M., S. Windsor, E. Winn-Deen, K. Wolfe, J. Zaveri, K. Zaveri, J. F. Abril, R. Guigo, M. J. Campbell, K. V. Sjolander, B. Karlak, A. Kejariwal, H. Mi, B. Lazareva, T. Hatton, A. Narechania, K. Diemer, A. Muruganujan, N. Guo, S. Sato, V. Bafna, S. Istrail, R. Lippert, R. Schwartz, B. Walenz, S. Yooseph, D. Allen, A. Basu, J. Baxendale, L. Blick, M. Caminha, J. Carnes-Stine, P. Caulk, Y. H. Chiang, M. Coyne, C. Dahlke, A. Mays, M. Dombroski, M. Donnelly, D. Ely, S. Esparham, C. Fosler, H. Gire, S. Glanowski, K. Glasser, A. Glodek, M. Gorokhov, K. Graham, B. Gropman, M. Harris, J. Heil, S. Henderson, J. Hoover, D. Jennings, C. Jordan, J. Jordan, J. Kasha, L. Kagan, C. Kraft, A. Levitsky, M. Lewis, X. Liu, J. Lopez, D. Ma, W. Majoros, J. McDaniel, S. Murphy, M. Newman, T. Nguyen, N. Nguyen, M. Nodell, S. Pan, J. Peck, M. Peterson, W. Rowe, R. Sanders, J. Scott, M. Simpson, T. Smith, A. Sprague, T. Stockwell, R. Turner, E. Venter, M. Wang, M. Wen, D. Wu, M. Wu, A. Xia, A. Zandieh & X. Zhu: The sequence of the human genome. Science 291, 1304-1351 (2001) (Pubitemid 32173090)
28. Lander E. S, L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, N. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, R. A. Gibbs, D. M. Muzny, S. E. Scherer, J. B. Bouck, E. J. Sodergren, K. C. Worley, C. M. Rives, J. H. Gorrell, M. L. Metzker, S. L. Naylor, R. S. Kucherlapati, D. L. Nelson, G. M. Weinstock, Y. Sakaki, A. Fujiyama, M. Hattori, T. Yada, A. Toyoda, T. Itoh, C. Kawagoe, H. Watanabe, Y. Totoki, T. Taylor, J. Weissenbach, R. Heilig, W. Saurin, F. Artiguenave, P. Brottier, T. Bruls, E. Pelletier, C. Robert, P. Wincker, D. R. Smith, L. Doucette-Stamm, M. Rubenfield, K. Weinstock, H. M. Lee, J. Dubois, A. Rosenthal, M. Platzer, G. Nyakatura, S. Taudien, A. Rump, H. Yang, J. Yu, J. Wang, G. Huang, J. Gu, L. Hood, L. Rowen, A. Madan, S. Qin, R. W. Davis, N. A. Federspiel, A. P. Abola, M. J. Proctor, R. M. Myers, J. Schmutz, M. Dickson, J. Grimwood, D. R. Cox, M. V. Olson, R. Kaul, N. Shimizu, K. Kawasaki, S. Minoshima, G. A. Evans, M. Athanasiou, R. Schultz, B. A. Roe, F. Chen, H. Pan, J. Ramser, H. Lehrach, R. Reinhardt, W. R. McCombie, M. de la Bastide, N. Dedhia, H. Blocker, K. Hornischer, G. Nordsiek, R. Agarwala, L. Aravind, J. A. Bailey, A. Bateman, S. Batzoglou, E. Birney, P. Bork, D. G. Brown, C. B. Burge, L. Cerutti, H. C. Chen, D. Church, M. Clamp, R. R. Copley, T. Doerks, S. R. Eddy, E. E. Eichler, T. S. Furey, J. Galagan, J. G. Gilbert, C. Harmon, Y. Hayashizaki, D. Haussler, H. Hermjakob, K. Hokamp, W. Jang, L. S. Johnson, T. A. Jones, S. Kasif, A. Kaspryzk, S. Kennedy, W. J. Kent, P. Kitts, E. V. Koonin, I. Korf, D. Kulp, D. Lancet, T. M. Lowe, A. McLysaght, T. Mikkelsen, J. V. Moran, N. Mulder, V. J. Pollara, C. P. Ponting, G. Schuler, J. Schultz, G. Slater, A. F. Smit, E. Stupka, J. Szustakowski, D. Thierry-Mieg, J. Thierry-Mieg, L. Wagner, J. Wallis, R. Wheeler, A. Williams, Y. I. Wolf, K. H. Wolfe, S. P. Yang, R. F. Yeh, F. Collins, M. S. Guyer, J. Peterson, A. Felsenfeld, K. A. Wetterstrand, A. Patrinos, M. J. Morgan, J. Szustakowki, P. de Jong, J. J. Catanese, K. Osoegawa, H. Shizuya, S. Choi & Y. J. Chen: Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001) (Pubitemid 32165345)
29. Eaton L: Human genome project completed. Bmj 326, 838 (2003)
30. Hughes T. R, M. Mao, A. R. Jones, J. Burchard, M. J. Marton, K. W. Shannon, S. M. Lefkowitz, M. Ziman, J. M. Schelter, M. R. Meyer, S. Kobayashi, C. Davis, H. Dai, Y. D. He, S. B. Stephaniants, G. Cavet, W. L. Walker, A. West, E. Coffey, D. D. Shoemaker, R. Stoughton, A. P. Blanchard, S. H. Friend & P. S. Linsley: Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 19, 342-347 (2001) (Pubitemid 32275343)
31. Kallioniemi A, O. P. Kallioniemi, D. Sudar, D. Rutovitz, J. W. Gray, F. Waldman & D. Pinkel: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818-821 (1992)
32. Heller M. J: DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng 4, 129-153 (2002) (Pubitemid 35217417)
33. Simon R, M. Mirlacher & G. Sauter: Tissue microarrays in cancer diagnosis. Expert Rev Mol Diagn 3, 421-430 (2003) (Pubitemid 36859290)
34. Haab B. B: Antibody arrays in cancer research. Mol Cell Proteomics 4, 377-383 (2005) (Pubitemid 40590557)
35. Dyrskjot L, T. Thykjaer, M. Kruhoffer, J. L. Jensen, N. Marcussen, S. Hamilton-Dutoit, H. Wolf & T. F. Orntoft: Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33, 90-96 (2003) (Pubitemid 36068689)
36. Blaveri E, J. P. Simko, J. E. Korkola, J. L. Brewer, F. Baehner, K. Mehta, S. Devries, T. Koppie, S. Pejavar, P. Carroll & F. M. Waldman: Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 11, 4044-4055 (2005) (Pubitemid 40791568)
37. Sanchez-Carbayo M, N. D. Socci, J. J. Lozano, W. Li, E. Charytonowicz, T. J. Belbin, M. B. Prystowsky, A. R. Ortiz, G. Childs & C. Cordon-Cardo: Gene Discovery in Bladder Cancer Progression using cDNA Microarrays. Am J Pathol 163, 505-516 (2003) (Pubitemid 36909413)
38. Wild P. J, A. Herr, C. Wissmann, R. Stoehr, A. Rosenthal, D. Zaak, R. Simon, R. Knuechel, C. Pilarsky & A. Hartmann: Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res 11, 4415-4429 (2005) (Pubitemid 40825632)
39. Aaboe M, N. Marcussen, K. M. Jensen, T. Thykjaer, L. Dyrskjot & T. F. Orntoft: Gene expression profiling of noninvasive primary urothelial tumours using microarrays. Br J Cancer 93, 1182-1190 (2005) (Pubitemid 41670704)
40. Hoque M. O, J. Lee, S. Begum, K. Yamashita, J. M. Engles, M. Schoenberg, W. H. Westra & D. Sidransky: High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density singlenucleotide polymorphism array. Cancer Res 63, 5723-5726 (2003) (Pubitemid 37187467)
41. Gu J, H. Zhao, C. P. Dinney, Y. Zhu, D. Leibovici, C. E. Bermejo, H. B. Grossman & X. Wu: Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res 11, 1408-1415 (2005) (Pubitemid 40315220)
42. Gu J, H. Barton Grossman, C. P. Dinney & X. Wu: The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence. Pharmacogenomics 6, 575-584 (2005) (Pubitemid 41341624)
43. Spruck C. H, 3rd, P. F. Ohneseit, M. Gonzalez-Zulueta, D. Esrig, N. Miyao, Y. C. Tsai, S. P. Lerner, C. Schmutte, A. S. Yang, R. Cote & et al.: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54, 784-788 (1994) (Pubitemid 24068337)
44. Dyrskjot L, M. Kruhoffer, T. Thykjaer, N. Marcussen, J. L. Jensen, K. Moller & T. F. Orntoft: Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64, 4040-4048 (2004) (Pubitemid 38697320)
45. Billerey C, D. Chopin, M. H. Aubriot-Lorton, D. Ricol, S. Gil Diez de Medina, B. Van Rhijn, M. P. Bralet, M. A. Lefrere-Belda, J. B. Lahaye, C. C. Abbou, J. Bonaventure, E. S. Zafrani, T. van der Kwast, J. P. Thiery & F. Radvanyi: Frequent FGFR3 mutations in papillary non-invasive bladder (pTa)tumors. Am J Pathol 158, 1955-1959 (2001) (Pubitemid 32545179)
46. Lindgren D, F. Liedberg, A. Andersson, G. Chebil, S. Gudjonsson, A. Borg, W. Mansson, T. Fioretos & M. Hoglund: Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q. Oncogene 25, 2685-2696 (2006)
47. Dyrskjot L, K. Zieger, M. Kruhoffer, T. Thykjaer, J. L. Jensen, H. Primdahl, N. Aziz, N. Marcussen, K. Moller & T. F. Orntoft: A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 11, 4029-4036 (2005) (Pubitemid 40791566)
48. Modlich O, H. B. Prisack, G. Pitschke, U. Ramp, R. Ackermann, H. Bojar, T. A. Vogeli & M. O. Grimm: Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles. Clin Cancer Res 10, 3410-3421 (2004) (Pubitemid 38685447)
49. Sanchez-Carbayo M, N. D. Socci, J. Lozano, F. Saint & C. Cordon-Cardo: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24, 778-789 (2006) (Pubitemid 46622045)
50. Blaveri E, J. L. Brewer, R. Roydasgupta, J. Fridlyand, S. DeVries, T. Koppie, S. Pejavar, K. Mehta, P. Carroll, J. P. Simko & F. M. Waldman: Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11, 7012-7022 (2005) (Pubitemid 41428761)
51. Veltman J. A, J. Fridlyand, S. Pejavar, A. B. Olshen, J. E. Korkola, S. DeVries, P. Carroll, W. L. Kuo, D. Pinkel, D. Albertson, C. Cordon-Cardo, A. N. Jain & F. M. Waldman: Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63, 2872-2880 (2003) (Pubitemid 36667159)
52. Koed K, C. Wiuf, L. L. Christensen, F. P. Wikman, K. Zieger, K. Moller, H. von der Maase & T. F. Orntoft: High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors. Cancer Res 65, 34-45 (2005) (Pubitemid 40070793)
53. Ntzani E. E & J. P. Ioannidis: Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 362, 1439-1444 (2003) (Pubitemid 37352879)
54. Ramaswamy S, K. N. Ross, E. S. Lander & T. R. Golub: A molecular signature of metastasis in primary solid tumors. Nat Genet 33, 49-54 (2003) (Pubitemid 36068681)
55. Glinsky G. V, O. Berezovska & A. B. Glinskii: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115, 1503-1521 (2005) (Pubitemid 40814659)
56. Kim J. H, T. Tuziak, L. Hu, Z. Wang, J. Bondaruk, M. Kim, G. Fuller, C. Dinney, H. B. Grossman, K. Baggerly,. Zhang & B. Czerniak: Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. Lab Invest 85, 532-549 (2005) (Pubitemid 40523945)
57. Sanchez-Carbayo M, N. D. Socci, J. J. Lozano, B. B. Haab & C. Cordon-Cardo: Profiling bladder cancer using targeted antibody arrays. Am J Pathol 168, 93-103 (2006) (Pubitemid 43062562)
58. Wu X, J. Gu, H. B. Grossman, C. I. Amos, C. Etzel, M. Huang, Q. Zhang, R. E. Millikan, S. Lerner, C. P. Dinney & M. R. Spitz: Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78, 464-479 (2006) (Pubitemid 43291228)
59. Moreno V, F. Gemignani, S. Landi, L. Gioia-Patricola, A. Chabrier, I. Blanco, S. Gonzalez, E. Guino, G. Capella & F. Canzian: Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 12, 2101-2108 (2006)
60. Takata R, T. Katagiri, M. Kanehira, T. Tsunoda, T. Shuin, T. Miki, M. Namiki, K. Kohri, Y. Matsushita, T. Fujioka & Y. Nakamura: Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling. Clin Cancer Res 11, 2625-2636 (2005) (Pubitemid 40569463)
61. Bulashevska S, O. Szakacs, B. Brors, R. Eils & G. Kovacs: Pathways of urothelial cancer progression suggested by Bayesian network analysis of allelotyping data. Int J Cancer 110, 850-856 (2004) (Pubitemid 38758511)
62. Salz W, D. Eisenberg, J. Plescia, D. S. Garlick, R. M. Weiss, X. R. Wu, T. T. Sun & D. C. Altieri: A survivin gene signature predicts aggressive tumor behavior. Cancer Res 65, 3531-3534 (2005) (Pubitemid 40616325)
63. Thykjaer T, C. Workman, M. Kruhoffer, K. Demtroder, H. Wolf, L. D. Andersen, C. M. Frederiksen, S. Knudsen & T. F. Orntoft: Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61, 2492-2499 (2001) (Pubitemid 32685829)